A prime-boost immunization strategy with DNA and recombinant baculovirus-expressed protein enhances protective immunogenicity of glycoprotein D of equine herpesvirus 1 in naive and infection-primed mice

Vaccine

Volumn 18, Issue 14, 2000, Pages 1367-1373

  Ruitenberg, Kirsten M ^a   Walker, Catherine ^a   Love, Daria N ^b   Wellington, Janet E ^a   Whalley, J Millar ^a  

^a Div Environ Life Sci M   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

DNA immunization; Equine herpesvirus 1; Recombinant baculovirus

Indexed keywords

GLYCOPROTEIN D; NEUTRALIZING ANTIBODY; PLASMID DNA; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BACULOVIRUS; CONTROLLED STUDY; EQUINE HERPES VIRUS; FEMALE; HELPER CELL; IMMUNIZATION; IMMUNOGENICITY; INOCULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS RECOMBINANT;

ANIMALS; BACULOVIRIDAE; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, EQUID; IMMUNIZATION, SECONDARY; INJECTIONS, INTRAMUSCULAR; MICE; MICE, INBRED BALB C; VACCINES, COMBINED; VACCINES, DNA; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS;

EID: 0033962164     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00400-4     Document Type: Article

References (31)

1. Allen G.P., Bryans J.T. Molecular epizootiology, pathogenesis and prophylaxis of equine herpesvirus-1 infections. Prog. Vet. Microbiol. Immunol. 2:1986;78-144.
2. Crabb B.S., Studdert M.J. Equine herpesvirus 4 (equine rhinopneumonitis virus) and 1 (equine abortion virus). Adv. Virus Res. 45:1995;153-190.
3. Slater J.D., Borchers K., Thackray A.M., Field H.J. The trigeminal ganglion is a location for equine herpesvirus 1 latency and reactivation in the horse. J. Gen. Virol. 75:1994;2007-2016.
4. Gilkerson J.R., Love D.N., Whalley J.M. A review of equine herpesviruses vaccines: from the traditional to the experimental. Aust. Equine Vet. 15:1997;27-32.
5. Karlin S., Mocarski E.S., Schachtel G.A. Molecular evolution of herpesviruses - genomic and protein sequence comparisons. J. Virol. 68:1994;1886-1902.
6. Walker C., Love D., Whalley J. Comparison of the pathogenesis of acute equine herpesvirus 1 (EHV-1) infection in the horse and the mouse model: a review. Vet. Microbiol. 68:1999;3-13.
7. Audonnet J.C., Winslow J., Allen G., Paoletti E. Equine herpesvirus type 1 unique short fragment encodes glycoproteins with homology to herpes simplex virus type 1 gD, gI and gE. J. Gen. Virol. 71:1990;2969-2978.
8. Flowers C.C., Eastman E.M., O'Callaghan D.J. Sequence analysis of a glycoprotein D gene homolog within the unique short segment of the EHV-1 genome. Virology. 180:1991;175-184.
9. Whalley M., Robertson G., Bell C., et al. Identification and comparative sequence analysis of a gene in equine herpesvirus 1 with homology to the herpes simplex virus glycoprotein D gene. Virus Genes. 5:1991;313-325.
10. Ruitenberg K.M., Walker C., Wellington J.E., Love D.N., Whalley J.M. DNA-mediated immunization with glycoprotein D of equine herpesvirus 1 (EHV-1) in a murine model of EHV-1 respiratory infection. Vaccine. 17:1999;237-244.
11. Grange M.P., Armand M.A., Audoly G., Thollot D., Desgranges C. Induction of neutralizing antibodies against HTLV-I envelope proteins after combined genetic and protein immunizations in mice. DNA Cell Biol. 16:1997;1439-1448.
12. Sedegah M., Jones T.R., Kaur M., et al. Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine. Proc. Natl. Acad. Sci. USA. 95:1998;7648-7653.
13. Ramsay A.J., Leong K.H., Ramshaw I.A. DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors. Immunol. Cell Biol. 75:1997;382-388.
14. Caver T.E., Lockey T.D., Srinivas R.V., Webster R.G., Hurwitz J.L. A novel vaccine regimen utilizing DNA, vaccinia virus and protein immunizations for HIV-1 envelope presentation. Vaccine. 17:1999;1567-1572.
15. Rothel J.S., Waterkeyn J.G., Strugnell R.A., et al. Nucleic acid vaccination of sheep - use in combination with a conventional adjuvanted vaccine against Taenia ovis. Immunol. Cell. Biol. 75:1997;41-46.
16. Rothel J.S., Boyle D.B., Both G.W., et al. Sequential nucleic acid and recombinant adenovirus vaccination induces host-protective immune responses against Taenia ovis infection in sheep. Parasite Immunol. 19:1997;221-227.
17. Tewari D., Whalley J.M., Love D.N., Field H.J. Characterization of immune responses to baculovirus-expressed equine herpesvirus type 1 glycoproteins D and H in a murine model. J. Gen. Virol. 75:1994;1735-1741.
18. Packiarajah P., Walker C., Gilkerson J., Whalley J.M., Love D.N. Immune responses and protective efficacy of recombinant baculovirus-expressed glycoproteins of equine herpesvirus 1 (EHV-1) gB, gC and gD alone or in combinations in BALB/c mice. Vet. Microbiol. 61:1998;261-278.
19. Wellington J.E., Lawrence G.L., Love D.N., Whalley J.M. Expression and characterization of equine herpesvirus 1 glycoprotein D in mammalian cell lines. Arch. Virol. 141:1996;1785-1793.
20. Love D.N., Bell C.W., Pye D., et al. Expression of equine herpesvirus-1 glycoprotein-D by using a recombinant baculovirus. J. Virol. 67:1993;6820-6823.
21. Ruitenberg K.M., Walker C., Wellington J.E., Love D.N., Whalley J.M. Potential of DNA-mediated vaccination for equine herpesvirus 1. Vet. Microbiol. 68:1999;35-48.
22. Donnelly J.J., Ulmer J.B., Shiver J.W., Liu M.A. DNA vaccines. Annu. Rev. Immunol. 15:1997;617-648.
23. Awan A.R., Chong Y.C., Field H.J. The pathogenesis of equine herpesvirus type 1 in the mouse: a new model for studying host responses to the infection. J. Gen. Virol. 71:1990;1131-1140.
24. Walker C., Packiarajah P., Gilkerson J.R., Love D.N., Whalley J.M. Primary and challenge infection of mice with equine herpesvirus 1, strain HVS25A. Virus Res. 57:1998;151-162.
25. Love D.N., Bell C.W., Whalley J.M. Characterization of the glycoprotein D gene products of equine herpesvirus 1 using a prokaryotic cell expression vector. Vet. Microbiol. 30:1992;387-394.
26. Wellington J.E., Gooley A.A., Love D.N., Whalley J.M.N. N-terminal sequence analysis of equine herpesvirus 1 glycoproteins D and B and evidence for internal cleavage of the gene 71 product. J. Gen. Virol. 77:1996;75-82.
27. Flowers C.C., O'Callaghan D.J. Equine herpesvirus 1 glycoprotein D: mapping of the transcript and a neutralization epitope. J. Virol. 66:1992;6451-6460.
28. Krieg A.M., Yi A.K., Schorr J., Davis H.L. The role of CpG dinucleotides in DNA vaccines. Trends Microbiol. 6:1998;23-27.
29. Klinman D.M., Yamshchikov G., Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol. 158:1997;3635-3639.
30. Gilkerson J.R., Love D.N., Whalley J.M. Serological evidence of equine herpesvirus 1 (EHV-1) infection in thoroughbred foals 30-120 days of age. Aust. Equine Vet. 15:1997;128-134.
31. Lunn D.P., Soboll G., Schram B.R., et al. Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene. Vaccine. 17:1999;2245-2258.